1	Interleukin-10	Interleukin-10	_	_	_	_	_	_	_
2	stabilizes	stabilize	_	_	_	_	_	_	_
3	inhibitory	inhibitory	_	_	_	_	_	_	_
4	kappaB-alpha	kappab-alpha	_	_	_	_	_	_	_
5	in	in	_	_	_	_	_	_	_
6	human	human	_	_	_	_	_	_	_
7	monocytes	monocyte	_	_	_	_	_	_	_
8	.	.	_	_	_	_	_	_	_

1	Interleukin-10	Interleukin-10	_	_	_	_	_	_	_
2	(	(	_	_	_	_	_	_	_
3	IL-10	IL-10	_	_	_	_	_	_	_
4	)	)	_	_	_	_	_	_	_
5	protects	protect	_	_	_	_	_	_	_
6	animals	animal	_	_	_	_	_	_	_
7	from	from	_	_	_	_	_	_	_
8	lethal	lethal	_	_	_	_	_	_	_
9	endotoxemia	endotoxemia	_	_	_	_	_	_	_
10	.	.	_	_	_	_	_	_	_

1	This	this	_	_	_	_	_	_	_
2	beneficial	beneficial	_	_	_	_	_	_	_
3	effect	effect	_	_	_	_	_	_	_
4	is	be	_	_	_	_	_	_	_
5	mediated	mediate	_	_	_	_	_	_	_
6	,	,	_	_	_	_	_	_	_
7	in	in	_	_	_	_	_	_	_
8	part	part	_	_	_	_	_	_	_
9	,	,	_	_	_	_	_	_	_
10	by	by	_	_	_	_	_	_	_
11	inhibition	inhibition	_	_	_	_	_	_	_
12	of	of	_	_	_	_	_	_	_
13	inflammatory	inflammatory	_	_	_	_	_	_	_
14	cytokine	cytokine	_	_	_	_	_	_	_
15	production	production	_	_	_	_	_	_	_
16	,	,	_	_	_	_	_	_	_
17	including	include	_	_	_	_	_	_	_
18	tumor	tumor	_	_	_	_	_	_	_
19	necrosis	necrosis	_	_	_	_	_	_	_
20	factor-alpha	factor-alpha	_	_	_	_	_	_	_
21	(	(	_	_	_	_	_	_	_
22	TNF-alpha	TNF-alpha	_	_	_	_	_	_	_
23	)	)	_	_	_	_	_	_	_
24	.	.	_	_	_	_	_	_	_

1	Evidence	evidence	_	_	_	_	_	_	_
2	suggests	suggest	_	_	_	_	_	_	_
3	that	that	_	_	_	_	_	_	_
4	IL-10	il-10	_	_	_	_	_	_	_
5	may	may	_	_	_	_	_	_	_
6	inhibit	inhibit	_	_	_	_	_	_	_
7	activation	activation	_	_	_	_	_	_	_
8	of	of	_	_	_	_	_	_	_
9	the	the	_	_	_	_	_	_	_
10	transcription	transcription	_	_	_	_	_	_	_
11	factor	factor	_	_	_	_	_	_	_
12	nuclear	nuclear	_	_	_	_	_	_	_
13	factor-kappaB	factor-kappaB	_	_	_	_	_	_	_
14	(	(	_	_	_	_	_	_	_
15	NF-kappaB	NF-kappaB	_	_	_	_	_	_	_
16	)	)	_	_	_	_	_	_	_
17	through	through	_	_	_	_	_	_	_
18	an	an	_	_	_	_	_	_	_
19	unknown	unknown	_	_	_	_	_	_	_
20	mechanism	mechanism	_	_	_	_	_	_	_
21	.	.	_	_	_	_	_	_	_

1	NF-kappaB	NF-kappaB	_	_	_	_	_	_	_
2	activation	activation	_	_	_	_	_	_	_
3	in	in	_	_	_	_	_	_	_
4	response	response	_	_	_	_	_	_	_
5	to	to	_	_	_	_	_	_	_
6	inflammatory	inflammatory	_	_	_	_	_	_	_
7	signals	signal	_	_	_	_	_	_	_
8	is	be	_	_	_	_	_	_	_
9	dependent	dependent	_	_	_	_	_	_	_
10	upon	upon	_	_	_	_	_	_	_
11	degradation	degradation	_	_	_	_	_	_	_
12	of	of	_	_	_	_	_	_	_
13	its	its	_	_	_	_	_	_	_
14	associated	associate	_	_	_	_	_	_	_
15	inhibitory	inhibitory	_	_	_	_	_	_	_
16	peptide	peptide	_	_	_	_	_	_	_
17	,	,	_	_	_	_	_	_	_
18	inhibitory	inhibitory	_	_	_	_	_	_	_
19	kappaB-alpha	kappab-alpha	_	_	_	_	_	_	_
20	(	(	_	_	_	_	_	_	_
21	IkappaB-alpha	IkappaB-alpha	_	_	_	_	_	_	_
22	)	)	_	_	_	_	_	_	_
23	.	.	_	_	_	_	_	_	_

1	We	we	_	_	_	_	_	_	_
2	hypothesized	hypothesize	_	_	_	_	_	_	_
3	that	that	_	_	_	_	_	_	_
4	IL-10	IL-10	_	_	_	_	_	_	_
5	prevents	prevent	_	_	_	_	_	_	_
6	human	human	_	_	_	_	_	_	_
7	monocyte	monocyte	_	_	_	_	_	_	_
8	NF-kappaB	nf-kappab	_	_	_	_	_	_	_
9	activation	activation	_	_	_	_	_	_	_
10	and	and	_	_	_	_	_	_	_
11	resultant	resultant	_	_	_	_	_	_	_
12	TNF-alpha	TNF-alpha	_	_	_	_	_	_	_
13	production	production	_	_	_	_	_	_	_
14	by	by	_	_	_	_	_	_	_
15	stabilization	stabilization	_	_	_	_	_	_	_
16	of	of	_	_	_	_	_	_	_
17	IkappaB-alpha	IkappaB-alpha	_	_	_	_	_	_	_
18	.	.	_	_	_	_	_	_	_

1	The	the	_	_	_	_	_	_	_
2	purpose	purpose	_	_	_	_	_	_	_
3	of	of	_	_	_	_	_	_	_
4	this	this	_	_	_	_	_	_	_
5	study	study	_	_	_	_	_	_	_
6	was	be	_	_	_	_	_	_	_
7	to	to	_	_	_	_	_	_	_
8	determine	determine	_	_	_	_	_	_	_
9	the	the	_	_	_	_	_	_	_
10	effect	effect	_	_	_	_	_	_	_
11	of	of	_	_	_	_	_	_	_
12	IL-10	il-10	_	_	_	_	_	_	_
13	on	on	_	_	_	_	_	_	_
14	lipopolysaccharide	lipopolysaccharide	_	_	_	_	_	_	_
15	(	(	_	_	_	_	_	_	_
16	LPS)-induced	lps)-induced	_	_	_	_	_	_	_
17	human	human	_	_	_	_	_	_	_
18	monocyte	monocyte	_	_	_	_	_	_	_
19	TNF-alpha	TNF-alpha	_	_	_	_	_	_	_
20	production	production	_	_	_	_	_	_	_
21	,	,	_	_	_	_	_	_	_
22	NF-kappaB	NF-kappaB	_	_	_	_	_	_	_
23	activation	activation	_	_	_	_	_	_	_
24	,	,	_	_	_	_	_	_	_
25	and	and	_	_	_	_	_	_	_
26	IkappaB-alpha	IkappaB-alpha	_	_	_	_	_	_	_
27	degradation	degradation	_	_	_	_	_	_	_
28	.	.	_	_	_	_	_	_	_

1	Monocytes	Monocyte	_	_	_	_	_	_	_
2	were	be	_	_	_	_	_	_	_
3	isolated	isolate	_	_	_	_	_	_	_
4	from	from	_	_	_	_	_	_	_
5	human	human	_	_	_	_	_	_	_
6	donors	donor	_	_	_	_	_	_	_
7	.	.	_	_	_	_	_	_	_

1	Cells	cell	_	_	_	_	_	_	_
2	were	be	_	_	_	_	_	_	_
3	stimulated	stimulate	_	_	_	_	_	_	_
4	with	with	_	_	_	_	_	_	_
5	endotoxin	endotoxin	_	_	_	_	_	_	_
6	(	(	_	_	_	_	_	_	_
7	LPS	LPS	_	_	_	_	_	_	_
8	,	,	_	_	_	_	_	_	_
9	100	100	_	_	_	_	_	_	_
10	ng/mL	ng/ml	_	_	_	_	_	_	_
11	)	)	_	_	_	_	_	_	_
12	with	with	_	_	_	_	_	_	_
13	and	and	_	_	_	_	_	_	_
14	without	without	_	_	_	_	_	_	_
15	human	human	_	_	_	_	_	_	_
16	IL-10	il-10	_	_	_	_	_	_	_
17	(	(	_	_	_	_	_	_	_
18	10	10	_	_	_	_	_	_	_
19	ng/mL	ng/ml	_	_	_	_	_	_	_
20	)	)	_	_	_	_	_	_	_
21	.	.	_	_	_	_	_	_	_

1	Following	follow	_	_	_	_	_	_	_
2	stimulation	stimulation	_	_	_	_	_	_	_
3	,	,	_	_	_	_	_	_	_
4	TNF-alpha	TNF-alpha	_	_	_	_	_	_	_
5	was	be	_	_	_	_	_	_	_
6	measured	measure	_	_	_	_	_	_	_
7	in	in	_	_	_	_	_	_	_
8	cell	cell	_	_	_	_	_	_	_
9	supernatants	supernatant	_	_	_	_	_	_	_
10	by	by	_	_	_	_	_	_	_
11	ELISA	ELISA	_	_	_	_	_	_	_
12	,	,	_	_	_	_	_	_	_
13	NF-kappaB	NF-kappaB	_	_	_	_	_	_	_
14	activity	activity	_	_	_	_	_	_	_
15	by	by	_	_	_	_	_	_	_
16	electrophoretic	electrophoretic	_	_	_	_	_	_	_
17	mobility	mobility	_	_	_	_	_	_	_
18	shift	shift	_	_	_	_	_	_	_
19	assay	assay	_	_	_	_	_	_	_
20	,	,	_	_	_	_	_	_	_
21	and	and	_	_	_	_	_	_	_
22	IkappaB-alpha	IkappaB-alpha	_	_	_	_	_	_	_
23	levels	level	_	_	_	_	_	_	_
24	by	by	_	_	_	_	_	_	_
25	Western	western	_	_	_	_	_	_	_
26	blot	blot	_	_	_	_	_	_	_
27	.	.	_	_	_	_	_	_	_

1	We	we	_	_	_	_	_	_	_
2	observed	observe	_	_	_	_	_	_	_
3	that	that	_	_	_	_	_	_	_
4	after	after	_	_	_	_	_	_	_
5	LPS	LPS	_	_	_	_	_	_	_
6	stimulation	stimulation	_	_	_	_	_	_	_
7	of	of	_	_	_	_	_	_	_
8	human	human	_	_	_	_	_	_	_
9	monocytes	monocyte	_	_	_	_	_	_	_
10	,	,	_	_	_	_	_	_	_
11	TNF-alpha	TNF-alpha	_	_	_	_	_	_	_
12	increased	increase	_	_	_	_	_	_	_
13	to	to	_	_	_	_	_	_	_
14	798+/-67	798+/-67	_	_	_	_	_	_	_
15	pg/mL	pg/ml	_	_	_	_	_	_	_
16	(	(	_	_	_	_	_	_	_
17	p	p	_	_	_	_	_	_	_
18	<	<	_	_	_	_	_	_	_
19	.001	.001	_	_	_	_	_	_	_
20	versus	versus	_	_	_	_	_	_	_
21	control	control	_	_	_	_	_	_	_
22	)	)	_	_	_	_	_	_	_
23	.	.	_	_	_	_	_	_	_

1	IL-10	IL-10	_	_	_	_	_	_	_
2	attenuated	attenuate	_	_	_	_	_	_	_
3	LPS-stimulated	lps-stimulated	_	_	_	_	_	_	_
4	TNF-alpha	TNF-alpha	_	_	_	_	_	_	_
5	production	production	_	_	_	_	_	_	_
6	(	(	_	_	_	_	_	_	_
7	297+/-54	297+/-54	_	_	_	_	_	_	_
8	;	;	_	_	_	_	_	_	_
9	p	p	_	_	_	_	_	_	_
10	<	<	_	_	_	_	_	_	_
11	.001	.001	_	_	_	_	_	_	_
12	versus	versus	_	_	_	_	_	_	_
13	LPS	lps	_	_	_	_	_	_	_
14	alone	alone	_	_	_	_	_	_	_
15	)	)	_	_	_	_	_	_	_
16	.	.	_	_	_	_	_	_	_

1	After	after	_	_	_	_	_	_	_
2	LPS	LPS	_	_	_	_	_	_	_
3	stimulation	stimulation	_	_	_	_	_	_	_
4	in	in	_	_	_	_	_	_	_
5	human	human	_	_	_	_	_	_	_
6	monocytes	monocyte	_	_	_	_	_	_	_
7	,	,	_	_	_	_	_	_	_
8	IkappaB-alpha	IkappaB-alpha	_	_	_	_	_	_	_
9	protein	protein	_	_	_	_	_	_	_
10	levels	level	_	_	_	_	_	_	_
11	decreased	decrease	_	_	_	_	_	_	_
12	,	,	_	_	_	_	_	_	_
13	and	and	_	_	_	_	_	_	_
14	NF-kappaB	NF-kappaB	_	_	_	_	_	_	_
15	DNA	DNA	_	_	_	_	_	_	_
16	binding	binding	_	_	_	_	_	_	_
17	increased	increase	_	_	_	_	_	_	_
18	.	.	_	_	_	_	_	_	_

1	IL-10	IL-10	_	_	_	_	_	_	_
2	pretreatment	pretreatment	_	_	_	_	_	_	_
3	prevented	prevent	_	_	_	_	_	_	_
4	LPS-induced	lps-induced	_	_	_	_	_	_	_
5	decreases	decrease	_	_	_	_	_	_	_
6	in	in	_	_	_	_	_	_	_
7	IkappaB-alpha	IkappaB-alpha	_	_	_	_	_	_	_
8	protein	protein	_	_	_	_	_	_	_
9	levels	level	_	_	_	_	_	_	_
10	and	and	_	_	_	_	_	_	_
11	attenuated	attenuate	_	_	_	_	_	_	_
12	NF-kappaB	NF-kappaB	_	_	_	_	_	_	_
13	DNA	DNA	_	_	_	_	_	_	_
14	binding	binding	_	_	_	_	_	_	_
15	.	.	_	_	_	_	_	_	_

1	IL-10	IL-10	_	_	_	_	_	_	_
2	appears	appear	_	_	_	_	_	_	_
3	to	to	_	_	_	_	_	_	_
4	prevent	prevent	_	_	_	_	_	_	_
5	activation	activation	_	_	_	_	_	_	_
6	of	of	_	_	_	_	_	_	_
7	NF-kappaB	NF-kappaB	_	_	_	_	_	_	_
8	by	by	_	_	_	_	_	_	_
9	preserving	preserve	_	_	_	_	_	_	_
10	IkappaB-alpha	IkappaB-alpha	_	_	_	_	_	_	_
11	protein	protein	_	_	_	_	_	_	_
12	levels	level	_	_	_	_	_	_	_
13	,	,	_	_	_	_	_	_	_
14	leading	lead	_	_	_	_	_	_	_
15	to	to	_	_	_	_	_	_	_
16	a	a	_	_	_	_	_	_	_
17	reduction	reduction	_	_	_	_	_	_	_
18	in	in	_	_	_	_	_	_	_
19	TNF-alpha	TNF-alpha	_	_	_	_	_	_	_
20	release	release	_	_	_	_	_	_	_
21	.	.	_	_	_	_	_	_	_

